Skip to main content
Mobile menu expand icon
Menu
Close
About Gimv
Investment platforms
Portfolio
Team
Sustainability
News
Investors
en
nl
fr
de
Search
About Gimv
Investment platforms
Portfolio
Team
Sustainability
News
Investors
Working at Gimv
Contact
Latest news Latest news Latest news
Latest news
Filter news
Authored on
*
(Optional)
Year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Category
*
(Optional)
Category
Corporate
Portfolio
Investment platform
*
(Optional)
Investment platform
Consumer
Healthcare
Life Sciences
Smart Industries
Sustainable Cities
Apply
Show all
Portfolio
Biotalys Achieves Breakthrough in Protein Expression Increasing Commercial Potential for its first BioFungicide Evoca
25/01/2022 - 07:00
Portfolio
JenaValve announces strategic investment and licensing agreement with Peijia Medical Limited
18/01/2022 - 08:00
Corporate
Gimv awarded as a Top-Rated ESG Performer by Sustainalytics
18/01/2022 - 08:00
Portfolio
Arseus Medical Group announces new partnership with Heart Medical Europe BV
13/01/2022 - 09:00
Portfolio
Biotalys and Olon enter into long-term partnership for the production of protein-based biocontrols
12/01/2022 - 07:00
Corporate
Interview VFB with Kristof Vande Capelle and Tom Van de Voorde
23/12/2021 - 14:00
Portfolio
Medi-Markt takes over mediclean Home Care Service
19/11/2021 - 10:00
Corporate
Significant growth at our companies produces excellent half year-results
18/11/2021 - 07:00
Portfolio
Gimv creates a strong national player for underground infrastructure through the strategic combination of Baas-Verkley
02/11/2021 - 17:45
Portfolio
Projective Group acquires Dutch consulting firm Mastermind
04/10/2021 - 20:00
Corporate
Trends Talk met Koen Dejonckheere - CEO Gimv
02/10/2021 - 11:00
Portfolio
Jens Pohl the new CEO at Smart Battery Solutions
27/09/2021 - 14:05
Pagination
See more news
Do you want to stay updated about Gimv news?
Subscribe to our press releases
Contact information
Investor Relations Investor Relations Investor Relations
Investor Relations
Do you have any questions or require more information? Please contact us.
Contact us